Table 3.

The values of assessed clinical and laboratory data (expressed as±SD) of subjects NAFLD and Non- NAFLD

Variables	Non-NAFLD n=534	NAFLD n=416	Crude OR (95% CI)	P*
Age (y)	46.94±7.45	47.39±7.06	1.009 (0.991-1.026)	0.34
Systolic BP	118.34±16.50	123.54±16.84	1.019 (1.011-1.027)	<0.001
Diastolic BP	79.03±11.16	82.83±11.25	1.031 (1.019-1.044)	<0.001
FBS (mg/dl)	97.51±24.7	109.11±38.05	1.013 (1.008-1.018)	<0.001
Biochemical markers
AST (U/L)	18.45±7.75	22.17±11.74	1.049 (1.031-1.068)	<0.001
ALT (U/L)	17.35±12.45	27.25±19.11	1.052 (1.040-1.065)	<0.001
ALP (U/L)	192.00±56.92	196.01±53.71	1.001 (0.999-1.004)	0.26
GGT (U/L)	23.31±18.26	33.31±27.65	1.031 (1.021-1.042)	<0.001
AST/ALT ratio	0.95±0.40	1.27±0.50	0.156 (0.106-0.230)	<0.001
Lipid profiles
TG (mg/dl)	150.71±85.55	201.22±97.94	1.006 (1.005-1.008)	<0.001
TC (mg/dl)	198.59±35.28	205.07±39.44	1.005 (1.001-1.008)	0.008
HDL-C (mg/dl)	46.61±9.77	43.47±8.65	0.964 (0.950-0.978)	<0.001
LDL-C (mg/dl)	121.10±29.71	121.82±32.50	0.999 (0.995-1.003)	0.72
LDL-C/HDL-C (ratio)	2.69±0.76	2.84±0.78	1.283 (1.086-1.517)	0.003
TC/HDL-C (ratio)	4.40±1.04	4.84±1.10	1.472 (1.299-1.668)	<0.001

NAFLD: Non-alcoholic fatty liver disease; FBS: Fasting blood sugar; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyltransferase; TG: Triglyceride; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol *P<0.05 is significant